SONOMA PHARMACEUTICALS, INC. (SNOA) Gross margin 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) gross margin by fiscal year — reported gross profit divided by reported revenue.
38.0%FY2026 · since FY2017: 44.2% → 38.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 38.0% | -0.3 pp |
| FY2025 | 38.2% | +1.0 pp |
| FY2024 | 37.3% | +3.5 pp |
| FY2023 | 33.7% | +2.1 pp |
| FY2022 | 31.6% | -3.6 pp |
| FY2021 | 35.2% | -10.1 pp |
| FY2020 | 45.3% | -1.5 pp |
| FY2019 | 46.8% | +2.9 pp |
| FY2018 | 43.9% | -0.3 pp |
| FY2017 | 44.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice